AVI BioPharma (AVII) (SRPT) Changes Name to 'Sarepta Therapeutics, Inc.'

Article Stock Quotes (2) Comments (0)

AVI BioPharma, Inc. (Nasdaq: AVII) has changed its name to Sarepta Therapeutics, Inc. ("the Company") and has effected a one-for-six reverse stock split. The name change and reverse stock split were approved by the Company's shareholders at its Annual Meeting of Shareholders held on July 10, 2012, and the specific one-for-six ratio was agreed upon and approved by the Company's Board of Directors. Sarepta is focused on the development of first-in-class RNA-based therapeutics to improve and save the lives of people affected by serious and life-threatening rare and infectious diseases. The Company's development programs include its lead therapeutic candidate, eteplirsen, for the treatment of Duchenne muscular dystrophy (DMD), as well as potential treatments for the lethal hemorrhagic fever viruses Ebola and Marburg.

The Company's common stock will trade on a split-adjusted basis on The NASDAQ Global Market when the market opens today, July 12, 2012, and will trade under the new ticker symbol (Nasdaq: SRPT).

---

Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW

---

*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here

---

---

You May Also Be Interested In

• A.G. Lafley Returns as President/CEO of Procter & Gamble (PG)
• Gleacher & Co. (GLCH) Reports Election of Five for Board Members
• Merck (MRK) Says Efficacy Not Achieved in Preladenant Phase 3s; Will Discontinue

Create E-mail Alert Related Categories

Corporate News, Stock Splits

Add Your Comment

Name

Subject

Body

Share on Facebook

Verification
can't see the text?
click here to refresh the image.
what's this?